Globus Medical (GMED) Liabilities and Shareholders Equity (2011 - 2026)

Globus Medical (GMED) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $5.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 15.46% year-over-year to $5.4 billion; the trailing twelve-month figure through Mar 2026 stood at $20.8 billion (up 3.77% YoY), and the FY2025 full-year result was $5.3 billion, up 0.97% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $5.4 billion, up from $5.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $5.4 billion in Q1 2026 and bottomed at $1.9 billion in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $5.0 billion (2025), against an average of $4.0 billion.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity soared 170.98%; it then retreated 5.04% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.1 billion in 2022, then surged by 144.98% to $5.1 billion in 2023, then climbed by 3.26% to $5.3 billion in 2024, then grew by 0.97% to $5.3 billion in 2025, then increased by 2.58% to $5.4 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $5.4 billion (Q1 2026), $5.3 billion (Q4 2025), and $5.1 billion (Q3 2025), per Business Quant data.

Peer Comparison